Healios K.K. Statistics
Total Valuation
Healios K.K. has a market cap or net worth of EUR 264.80 million. The enterprise value is 248.04 million.
| Market Cap | 264.80M |
| Enterprise Value | 248.04M |
Important Dates
The last earnings date was Monday, February 16, 2026.
| Earnings Date | Feb 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 135.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +21.68% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 69.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 468.71 |
| PB Ratio | 9.95 |
| P/TBV Ratio | 102.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -20.60 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.70 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.53.
| Current Ratio | 2.00 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.78 |
| Interest Coverage | -16.70 |
Financial Efficiency
Return on equity (ROE) is -63.84% and return on invested capital (ROIC) is -34.06%.
| Return on Equity (ROE) | -63.84% |
| Return on Assets (ROA) | -13.36% |
| Return on Invested Capital (ROIC) | -34.06% |
| Return on Capital Employed (ROCE) | -24.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 8,691 |
| Profits Per Employee | -185,279 |
| Employee Count | 65 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Healios K.K. has paid 559,514 in taxes.
| Income Tax | 559,514 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.26% |
| 50-Day Moving Average | 1.75 |
| 200-Day Moving Average | 2.56 |
| Relative Strength Index (RSI) | 48.88 |
| Average Volume (20 Days) | 8 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healios K.K. had revenue of EUR 564,946 and -12.04 million in losses. Loss per share was -0.11.
| Revenue | 564,946 |
| Gross Profit | -619,268 |
| Operating Income | -18.14M |
| Pretax Income | -11.55M |
| Net Income | -12.04M |
| EBITDA | -16.65M |
| EBIT | -18.14M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 30.85 million in cash and 14.19 million in debt, with a net cash position of 16.66 million.
| Cash & Cash Equivalents | 30.85M |
| Total Debt | 14.19M |
| Net Cash | 16.66M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 26.61M |
| Book Value Per Share | 0.23 |
| Working Capital | 17.48M |
Cash Flow
In the last 12 months, operating cash flow was -17.19 million and capital expenditures -912,606, giving a free cash flow of -18.11 million.
| Operating Cash Flow | -17.19M |
| Capital Expenditures | -912,606 |
| Free Cash Flow | -18.11M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -109.62% |
| Operating Margin | -3,211.54% |
| Pretax Margin | -2,044.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Healios K.K. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.68% |
| Shareholder Yield | -21.68% |
| Earnings Yield | -4.55% |
| FCF Yield | -6.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healios K.K. has an Altman Z-Score of 1.84 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 2 |